Loading...
Docoh

Accelerate Diagnostics (AXDX)

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.

Company profile

Ticker
AXDX
Exchange
CEO
John Phillips
Employees
Incorporated
Location
Fiscal year end
Former names
ACCELR8 TECHNOLOGY CORP
SEC CIK
Subsidiaries
Accelerate Diagnostics UK Limited • Accelerate Diagnostics S.L. • Accelerate Diagnostics GmbH • Accelerate Diagnostics SARL • Accelerate Diagnostics B.V. • Accelerate Diagnostics Holdings, LLC ...
IRS number
841072256

AXDX stock data

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

16 May 22
13 Aug 22
31 Dec 22
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 13.65M 13.65M 13.65M 13.65M 13.65M 13.65M
Cash burn (monthly) 8.75M 2.42M 5.3M 6.24M 4.2M 3.88M
Cash used (since last report) 38.71M 10.72M 23.44M 27.6M 18.59M 17.17M
Cash remaining -25.05M 2.93M -9.79M -13.95M -4.94M -3.51M
Runway (months of cash) -2.9 1.2 -1.8 -2.2 -1.2 -0.9

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
22 Jun 22 Phillips Jack Common Stock Sell Dispose S No No 0.91 28,198 25.66K 242,035
22 Jun 22 Phillips Jack Common Stock Option exercise Acquire M No No 0 62,160 0 270,233
22 Jun 22 Phillips Jack RSU Common Stock Option exercise Dispose M No No 0 62,160 0 62,160
31 May 22 Francesconi Louise RSU Common Stock Grant Acquire A No No 0 75,949 0 75,949
55.8% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 107 106 +0.9%
Opened positions 13 16 -18.8%
Closed positions 12 15 -20.0%
Increased positions 29 45 -35.6%
Reduced positions 33 24 +37.5%
13F shares Current Prev Q Change
Total value 128.55M 245.03M -47.5%
Total shares 38.89M 39.81M -2.3%
Total puts 158.9K 193.5K -17.9%
Total calls 12.3K 12K +2.5%
Total put/call ratio 12.9 16.1 -19.9%
Largest owners Shares Value Change
Schuler Jack W 18.28M $90.69M 0.0%
Oracle Investment Management 2.73M $3.93M -24.7%
BLK Blackrock 2.3M $3.32M -2.2%
Baird Financial 1.74M $2.51M +15.5%
Griffin Asset Management 1.5M $2.16M +48.9%
Vanguard 1.32M $1.9M -26.6%
STT State Street 1.23M $1.78M +12.9%
Cannell Peter B & Co 1.09M $1.57M 0.0%
AXAHF Axa 913.51K $1.32M -32.1%
Blair William & Co 667.1K $961K -1.1%
Largest transactions Shares Bought/sold Change
Oracle Investment Management 2.73M -895.69K -24.7%
Griffin Asset Management 1.5M +493.1K +48.9%
Vanguard 1.32M -478.53K -26.6%
AXAHF Axa 913.51K -432.51K -32.1%
Russell Investments 0 -338.42K EXIT
Baird Financial 1.74M +233.48K +15.5%
Nuveen Asset Management 255.49K -184.16K -41.9%
Parametric Portfolio Associates 227.9K +177.85K +355.3%
Cladis Investment Advisory 565.4K +164.5K +41.0%
STT State Street 1.23M +140.88K +12.9%

Financial report summary

?

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: advance, albeit, Arc, ArcTM, attain, begun, beneficial, bifurcated, bond, build, commitment, committed, COVID, daily, detrimental, difficulty, driven, ease, employment, enable, enabling, environment, equitable, exceed, expenditure, favorable, fourth, front, half, hand, iii, incorporate, laser, layer, leaving, leveraging, lifted, lingering, location, margin, negotiated, obsolete, Omicron, point, premium, produce, proper, proven, quotient, refinanced, refinancing, reliable, retrospective, satisfaction, science, shortly, stipulated, strategy, successfully, superior, transition, troubled, trustee, unclear, view, vintage, work, working
Removed: accreted, addressing, administered, affiliated, agree, allocate, annum, apply, approved, assigned, assignment, authorization, bad, Brown, Chief, Clarifying, complexity, cumulatively, cutting, deducting, demonstration, derivative, determination, disbursement, established, evidencing, examination, execution, expansion, external, fewer, Flexibility, forfeited, forgiven, herd, hierarchy, immunity, impacting, impeding, improved, Imputation, impute, informed, installed, interaction, IRS, John, Joint, judgmental, larger, lender, long, maintaining, Matthew, Miller, mortgage, netted, nonconvertible, November, obligor, originally, Patience, Paycheck, permitted, PPP, prescribed, President, promissory, qualify, reinvesting, released, Relief, rent, representing, SBA, scope, separately, separating, Simplifying, Small, Strobeck, study, submitted, taxable, unchanged, vaccination, week

Patents

Utility
Instrument and System for Rapid Microorganism Identification and Antimicrobial Agent Susceptibility Testing
26 May 22
A system for automated microorganism identification and antibiotic susceptibility testing comprising a reagent cartridge, a reagent stage, a cassette, a cassette, stage, a pipettor assembly, an optical detection system, and a controller is disclosed.
Utility
Sensitive and Rapid Determination of Antimicrobial Susceptibility
31 Mar 22
The present invention relates to moving microorganisms to a surface, where they are grown in the presence and absence of antimicrobials, and by monitoring the growth of the microorganisms over time in the two conditions, their susceptibility to the antimicrobials can be determined.
Utility
Lens-free Holographic Optical System for High Sensitivity Label-free Microbial Growth Detection and Quantification for Screening, Identification, and Susceptibility Testing
3 Mar 22
Disclosed are optical interrogation apparatus that can produce lens-free images using an optoelectronic sensor array to generate a holographic image of sample objects, such as microorganisms in a sample.
Utility
Lens-free Holographic Optical System for High Sensitivity Label-free Microbial Growth Detection and Quantification for Screening, Identification, and Susceptibility Testing
13 Jan 22
Disclosed are optical interrogation apparatus that can produce lens-free images using an optoelectronic sensor array to generate a holographic image of sample objects, such as microorganisms in a sample.
Utility
Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
10 Aug 21
A system for automated microorganism identification and antibiotic susceptibility testing comprising a reagent cartridge, a reagent stage, a cassette, a cassette, stage, a pipettor assembly, an optical detection system, and a controller is disclosed.